Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-Fluorouracil.

Alyssa K DeZeeuwMichael F BassettiEvie H CarchmanCharles P HeiseDana HaydenElise H LawsonCristina B SangerRay KingNoelle K LoConteSam J LubnerJeremy D KratzDustin A Deming

Published in: Cancers (2024)

This study demonstrates promising tolerability and efficacy for weekly C/P chemoradiation for patients with anal cancer unable to receive mitomycin and 5-fluorouracil. This regimen merits further investigation in prospective clinical trials.

Keyphrases

papillary thyroid
clinical trial
rectal cancer
squamous cell
end stage renal disease
ejection fraction
locally advanced
newly diagnosed
high grade
lymph node metastasis
open label
squamous cell carcinoma
childhood cancer
phase ii study
radiation therapy
phase iii
young adults
patient reported
placebo controlled